Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) E10: HK$0.15 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:09989 Shenzhen Hepalink Pharmaceutical Group Co Ltd HKSE:09989
83 GF Score
Price HK$4.53
GF Value HK$4.59
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Shenzhen Hepalink Pharmaceutical Group Co E10?

Shenzhen Hepalink Pharmaceutical Group Co HKSE:09989 +6.09% 83 E10 is HK$0.15 as of Mar. 2026. GuruFocus rates HKSE:09989 with a GF Score™ of 83/100 and a GF Value™ of HK$4.59 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shenzhen Hepalink Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Mar. 2026 was HK$0.145. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is HK$0.15 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shenzhen Hepalink Pharmaceutical Group Co's average E10 Growth Rate was -7.90% per year. During the past 3 years, the average E10 Growth Rate was -7.20% per year. During the past 5 years, the average E10 Growth Rate was -6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Shenzhen Hepalink Pharmaceutical Group Co was -5.50% per year. The lowest was -9.10% per year. And the median was -8.10% per year.

As of today (2026-08-20), Shenzhen Hepalink Pharmaceutical Group Co's current stock price is HK$4.53. Shenzhen Hepalink Pharmaceutical Group Co's E10 for the quarter that ended in Mar. 2026 was HK$0.15. Shenzhen Hepalink Pharmaceutical Group Co's Shiller PE Ratio of today is 30.20.

During the past 13 years, the highest Shiller PE Ratio of Shenzhen Hepalink Pharmaceutical Group Co was 49.98. The lowest was 20.62. And the median was 32.00.


Shenzhen Hepalink Pharmaceutical Group Co  (HKSE:09989) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shenzhen Hepalink Pharmaceutical Group Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=4.53/0.15
=30.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Shenzhen Hepalink Pharmaceutical Group Co was 49.98. The lowest was 20.62. And the median was 32.00.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Shenzhen Hepalink Pharmaceutical Group Co E10 Related Terms


Shenzhen Hepalink Pharmaceutical Group Co E10 Historical Data

* Premium members only.

The historical data trend for Shenzhen Hepalink Pharmaceutical Group Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Hepalink Pharmaceutical Group Co E10 Chart

Shenzhen Hepalink Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.21 0.19 0.11 0.14 0.16

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.17 0.17 0.16 0.15

HKSE:09989 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Hepalink Pharmaceutical Group Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Hepalink Pharmaceutical Group Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Hepalink Pharmaceutical Group Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shenzhen Hepalink Pharmaceutical Group Co's Shiller PE Ratio falls into.


HKSE:09989
83GF Score
Shenzhen Hepalink Pharmaceutical Group Co Ltd HKSE:09989
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen Hepalink Pharmaceutical Group Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shenzhen Hepalink Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.145/116.3033*116.3033
=0.145

Current CPI (Mar. 2026) = 116.3033.

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.062 101.400 0.071
201609 0.035 102.400 0.040
201612 0.086 102.600 0.097
201703 -0.011 103.200 -0.012
201706 0.018 103.100 0.020
201709 0.075 104.100 0.084
201712 0.108 104.500 0.120
201803 0.069 105.300 0.076
201806 0.151 104.900 0.167
201809 0.189 106.600 0.206
201812 0.128 106.500 0.140
201903 0.475 107.700 0.513
201906 0.036 107.700 0.039
201909 0.110 109.800 0.117
201912 0.346 111.200 0.362
202003 0.226 112.300 0.234
202006 0.286 110.400 0.301
202009 0.104 111.700 0.108
202012 0.249 111.500 0.260
202103 0.117 112.662 0.121
202106 0.160 111.769 0.166
202109 0.101 112.215 0.105
202112 -0.184 113.108 -0.189
202203 0.197 114.335 0.200
202206 0.221 114.558 0.224
202209 0.107 115.339 0.108
202212 0.057 115.116 0.058
202303 0.052 115.116 0.053
202306 0.042 114.558 0.043
202309 0.014 115.339 0.014
202312 -0.691 114.781 -0.700
202403 0.115 115.227 0.116
202406 0.373 114.781 0.378
202409 0.087 115.785 0.087
202412 -0.097 114.893 -0.098
202503 0.114 115.116 0.115
202506 0.198 114.907 0.200
202509 0.098 115.471 0.099
202512 -0.154 115.832 -0.155
202603 0.145 116.303 0.145

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of HK$0.15 mean?
Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) has a E10 of HK$0.15 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shenzhen Hepalink Pharmaceutical Group Co and its competitors.
Is Shenzhen Hepalink Pharmaceutical Group Co's E10 too high?
Shenzhen Hepalink Pharmaceutical Group Co's current E10 is HK$0.15. Overall, Shenzhen Hepalink Pharmaceutical Group Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Hepalink Pharmaceutical Group Co's E10 compare to ZTS?
Shenzhen Hepalink Pharmaceutical Group Co's E10 of HK$0.15 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shenzhen Hepalink Pharmaceutical Group Co and its competitors. Shenzhen Hepalink Pharmaceutical Group Co's current E10 is HK$0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Hepalink Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) is currently considered Fairly Valued. The stock's GF Value™ is HK$4.59, compared to a current price of HK$4.53 — trading 1.3% below its estimated fair value. The current E10 is HK$0.15. Shenzhen Hepalink Pharmaceutical Group Co's overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989), the current E10 is HK$0.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) Overvalued in 2026?

Based on GuruFocus' analysis, Shenzhen Hepalink Pharmaceutical Group Co stock appears to be undervalued. The current stock price of HK$4.53 is trading 1.3% below its estimated GF Value™ of HK$4.59. GuruFocus considers Shenzhen Hepalink Pharmaceutical Group Co to be Fairly Valued.

Key valuation signals for HKSE:09989:

  • E10: HK$0.15
  • GF Value™: HK$4.59 vs. price of HK$4.53 (1.3% below fair value)
  • GF Score™: 83/100 with 6 warning signs

No single metric tells the full story. See the HKSE:09989 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shenzhen Hepalink Pharmaceutical Group Co Business Description

Other Exchanges 002399:China
Address No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company. Along with its subsidiary, it is engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading, and biopharmaceutical research and development in Asia, Europe, North America, and Australia, and investment business in Asia and North America. The Group mainly operates three main business segments, including the Finished dose pharmaceutical products; Active pharmaceutical ingredients; CDMO business; and Others. The geographical presence of the company is in Hong Kong, the United States of America, Europe, Mainland China, and Other countries. The majority of the company's revenue comes from Europe and the USA.
83GF Score

Get the complete analysis for HKSE:09989

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$4.53
Price
HK$4.59
GF Value